The accuracy of human papillomavirus vaccination status based on adult proxy recall or household immunization records for adolescent females in the United States: Results from the National Immunization Survey-Teen

Annals of Epidemiology

Volumn 23, Issue 5, 2013, Pages 281-285

  Ojha, Rohit P ^a   Tota, Joseph E ^b   Offutt Powell, Tabatha N ^c   Klosky, James L ^a   Ashokkumar, Ramkumar ^a   Gurney, James G ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b MCGILL UNIVERSITY   (Canada)

^c Delaware Health and Social Services   (United States)

Author keywords

Accuracy; Adolescents; Human papillomavirus; Immunization records; Misclassification; Recall; Vaccination

Indexed keywords

WART VIRUS VACCINE;

ACCURACY; ADOLESCENT; ARTICLE; CONTROLLED STUDY; ETHNICITY; FEMALE; HEALTH CARE SURVEY; HEALTH STATUS; HOUSEHOLD; HUMAN; IMMUNIZATION; MAJOR CLINICAL STUDY; MEDICAL RECORD; OUTCOME ASSESSMENT; POPULATION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; UNITED STATES; WART VIRUS;

ADOLESCENT; ADULT; FAMILY CHARACTERISTICS; FEMALE; HEALTH CARE SURVEYS; HUMANS; IMMUNIZATION PROGRAMS; MENTAL RECALL; MOTHERS; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PROXY; QUESTIONNAIRES; SENSITIVITY AND SPECIFICITY; UNITED STATES; VACCINATION;

EID: 84876849963     PISSN: 10472797     EISSN: 18732585     Source Type: Journal    
DOI: 10.1016/j.annepidem.2013.02.002     Document Type: Article

References (40)

1. Frazer I.H., Leggatt G.R., Mattarollo S.R. Prevention and treatment of papillomavirus-related cancers through immunization. Annu Rev Immunol 2011, 29:111-138.
2. Lowy D.R., Solomon D., Hildesheim A., Schiller J.T., Schiffman M. Human papillomavirus infection and the primary and secondary prevention of cervical cancer. Cancer 2008, 113:1980-1993.
3. Markowitz L.E., Dunne E.F., Saraiya M., Lawson H.W., Chesson H., Unger E.R. quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2007, 56:1-24. Centers for Disease Control and Prevention (CDC); Advisory Committee on Immunization Practices (ACIP).
4. FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2010, 59:626-629.
5. Recommendations on the use of quadrivalent human papillomavirus vaccine in males-Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morb Mortal Wkly Rep 2011, 60:1705-1708.
6. Anhang Price R., Tiro J.A., Saraiya M., Meissner H., Breen N. Use of human papillomavirus vaccines among young adult women in the United States: an analysis of the 2008 National Health Interview Survey. Cancer 2011, 117:5560-5568.
7. Berry-Caban C.S., Buenaventura J.B. HPV vaccination coverage among adolescents aged 9 to 17 years in a United States military treatment facility. Int J Adolesc Med Health 2009, 21:567-570.
8. Etter D.J., Zimet G.D., Rickert V.I. Human papillomavirus vaccine in adolescent women: a 2012 update. Curr Opin Obstet Gynecol 2012, 24:305-310.
9. Gold R., Naleway A.L., Jenkins L.L., Riedlinger K.K., Kurosky S.K., Nystrom R.J., et al. Completion and timing of the three-dose human papillomavirus vaccine series among adolescents attending school-based health centers in Oregon. Prev Med 2011, 52:456-458.
10. Guerry S.L., De Rosa C.J., Markowitz L.E., Walker S., Liddon N., Kerndt P.R., et al. Human papillomavirus vaccine initiation among adolescent girls in high-risk communities. Vaccine 2011, 29:2235-2241.
11. Kramer M.R., Dunlop A.L. Inter-state variation in human papilloma virus vaccine coverage among adolescent girls in the 50 US states, 2007. Matern Child Health J 2012, 16(Suppl. 1):S102-S110.
12. Laz T.H., Rahman M., Berenson A.B. An update on human papillomavirus vaccine uptake among 11-17 year old girls in the United States: National Health Interview Survey, 2010. Vaccine 2012, 30:3534-3540.
13. Liddon N.C., Leichliter J.S., Markowitz L.E. Human papillomavirus vaccine and sexual behavior among adolescent and young women. Am J Prev Med 2012, 42:44-52.
14. Lindley M.C., Smith P.J., Rodewald L.E. Vaccination coverage among U.S. adolescents aged 13-17 years eligible for the Vaccines for Children program, 2009. Public Health Rep 2011, 126(Suppl. 2):124-134.
15. LoMurray K., Sander M. Using the North Dakota Immunization Information System to determine adolescent vaccination rates and uptake. Public Health Rep 2011, 126(Suppl. 2):78-86.
16. Palli S.R., Mehta S., Aparasu R.R. Prevalence and predictors of human papillomavirus vaccination in adolescent girls. J Am Pharm Assoc 2012, 52:52-58.
17. Rees-Clayton E., Montgomery J.P., Enger K.S., Boulton M.L. Trends in Michigan early adolescent immunization: 2006-2008. Am J Public Health 2012, 102:1735-1741.
18. Sadigh G., Dempsey A.F., Ruffin M., Resnicow K., Carlos R.C. National patterns in human papillomavirus vaccination: an analysis of the National Survey of Family Growth. Hum Vaccin Immunother 2012, 8:234-242.
19. Schluterman N.H., Terplan M., Lydecker A.D., Tracy J.K. Human papillomavirus (HPV) vaccine uptake and completion at an urban hospital. Vaccine 2011, 29:3767-3772.
20. Stokley S., Cohn A., Dorell C., Hariri S., Yankey D., Messonnier N., et al. Adolescent vaccination-coverage levels in the United States: 2006-2009. Pediatrics 2011, 128:1078-1086.
21. Taylor L.D., Hariri S., Sternberg M., Dunne E.F., Markowitz L.E. Human papillomavirus vaccine coverage in the United States, National Health and Nutrition Examination Survey, 2007-2008. Prev Med 2011, 52:398-400.
22. Tiro J.A., Tsui J., Bauer H.M., Yamada E., Kobrin S., Breen N. Human papillomavirus vaccine use among adolescent girls and young adult women: an analysis of the 2007 California Health Interview Survey. J Womens Health (Larchmt) 2012, 21:656-665.
23. Wong C.A., Berkowitz Z., Dorell C.G., Anhang Price R., Lee J., Saraiya M. Human papillomavirus vaccine uptake among 9- to 17-year-old girls: National Health Interview Survey, 2008. Cancer 2011, 117:5612-5620.
24. Kessels S.J., Marshall H.S., Watson M., Braunack-Mayer A.J., Reuzel R., Tooher R.L. Factors associated with HPV vaccine uptake in teenage girls: a systematic review. Vaccine 2012, 30:3546-3556.
25. Garcini L.M., Galvan T., Barnack-Tavlaris J.L. The study of human papillomavirus (HPV) vaccine uptake from a parental perspective: a systematic review of observational studies in the United States. Vaccine 2012, 30:4588-4595.
26. Bartlett J.A., Peterson J.A. The uptake of human papillomavirus (HPV) vaccine among adolescent females in the United States: a review of the literature. J Sch Nurs 2011, 27:434-446.
27. Nelson L.M., Longstreth W.T., Koepsell T.D., van Belle G. Proxy respondents in epidemiologic research. Epidemiol Rev 1990, 12:71-86.
28. Centers for Disease Control and Prevention. Datasets for the National Immunization Survey - Teen. ; 2012. http://www.cdc.gov/nchs/nis/data_files_teen.htm.
29. Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, National Center for Health Statistics. National Immunization Survey-Teen: a user's guide for the 2010 public-use data file. ; 2012. http://ftp://ftp.cdc.gov/pub/Health_Statistics/NCHS/Dataset_Documentation/NIS/NISteenPUF10_DUG.pdf.
30. Pepe M.S. Measures of accuracy for binary tests. The statistical evaluation of medical tests for classification and prediction 2003, 14-34. Oxford University Press, New York.
31. Wacholder S., Armstrong B., Hartge P. Validation studies using an alloyed gold standard. Am J Epidemiol 1993, 137:1251-1258.
32. Burnum J.F. The misinformation era: the fall of the medical record. Ann Intern Med 1989, 110:482-484.
33. Siegler E.L. The evolving medical record. Ann Intern Med 2010, 153:671-677.
34. Joura E.A., Kjaer S.K., Wheeler C.M., Sigurdsson K., Iversen O.E., Hernandez-Avila M., et al. HPV antibody levels and clinical efficacy following administration of a prophylactic quadrivalent HPV vaccine. Vaccine 2008, 26:6844-6851.
35. Potthoff R.F. Telephone sampling in epidemiologic research: to reap the benefits, avoid the pitfalls. Am J Epidemiol 1994, 139:967-978.
36. Voigt L.F., Schwartz S.M., Doody D.R., Lee S.C., Li C.I. Feasibility of including cellular telephone numbers in random digit dialing for epidemiologic case-control studies. Am J Epidemiol 2011, 173:118-126.
37. Dorell C.G., Jain N., Yankey D. Validity of parent-reported vaccination status for adolescents aged 13-17 years: National Immunization Survey-Teen, 2008. Public Health Rep 2011, 126(Suppl. 2):60-69.
38. Stupiansky N.W., Zimet G.D., Cummings T., Fortenberry J.D., Shew M. Accuracy of self-reported human papillomavirus vaccine receipt among adolescent girls and their mothers. J Adolesc Health 2012, 50:103-105.
39. Centers for Disease Control and Prevention National and state vaccination coverage among adolescents aged 13 through 17 years-United States, 2010. MMWR Morb Mortal Wkly Rep 2011, 60:1117-1123.
40. Lash T.L., Fox M.P., Fink A.K. Applying quantitative bias analysis to epidemiologic data 2009, Springer Science+Business Media, New York.